Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)
DAN-RSV
Approved small_molecule active
Quick answer
Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant) for RSV-infection is a Approved program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- RSV-infection
- Phase
- Approved
- Modality
- small_molecule
- Status
- active